Difference between revisions of "Team:Munich/Testing"

Line 223: Line 223:
 
<div class="slider">
 
<div class="slider">
 
 
−
<input type="radio" name="slide_switch" id="id3" checked="checked"/>
+
<input type="radio" name="slide_switch" id="id1" checked="checked"/>
−
<label for="id3">
+
<label for="id1">
 
<img src="https://static.igem.org/mediawiki/2017/7/7e/T--Munich--Review2017_19.jpeg" width="100"/>
 
<img src="https://static.igem.org/mediawiki/2017/7/7e/T--Munich--Review2017_19.jpeg" width="100"/>
 
</label>
 
</label>
Line 235: Line 235:
 
<img src="https://static.igem.org/mediawiki/2017/d/dd/T--Munich--Review2017_14.jpeg" width=900/>
 
<img src="https://static.igem.org/mediawiki/2017/d/dd/T--Munich--Review2017_14.jpeg" width=900/>
  
−
<input type="radio" name="slide_switch" id="id1"/>
+
<input type="radio" name="slide_switch" id="id3"/>
−
<label for="id1">
+
<label for="id3">
 
<img src="https://static.igem.org/mediawiki/2017/b/b8/T--Munich--Review2017_5.jpeg" width="100"/>
 
<img src="https://static.igem.org/mediawiki/2017/b/b8/T--Munich--Review2017_5.jpeg" width="100"/>
 
</label>
 
</label>

Revision as of 23:07, 14 December 2017

Description

Design

Demonstrate

Measurement

Applied Design

Final Results

Achievements

Protocols

Notebook

Safety

Parts

Improved Part

Part Collection

InterLab

Model

Software

Collaboration

Detector

Quake Valve

Paperstrips

Sample Processing

Silver

Gold

Engagement

Collaborations

Team members

Sponsors

Attributions

Gallery

Abstract

The ongoing crisis of increasing antibiotic resistance demands innovative preventive strategies. Recently, the RNA-targeting protein CRISPR-Cas13a has been used for highly sensitive DNA and RNA detection, promising diverse applications in point-of-care diagnostics. We integrated Cas13a in the detection unit of CascAID, our GMO-free diagnostic platform. CascAID combines an automated microfluidic device for rapid lysis and extraction of nucleic acids with a paper-based readout system. We demonstrated the performance of our device by targeting the 16S rRNA from E. coli. We improved the detection limit of our platform, using simulations to optimize our amplification scheme and the final readout.

Conceived as a distributable platform for rapid point-of-care diagnostics, CascAID can be used to distinguish between bacterial and viral infections, thus minimizing the widespread use of antibiotics. Furthermore, Cas13a allows the fast design of target sequences, making our system adaptive to the emergence of new viral outbreaks or fast mutating pathogens.

Awards & Achievements

First Runner-up

Best Diagnostics Project

Best Model

Best Applied Design

Best Hardware

Best Software

Nominated for Best Wiki

Nominated for Best Presentation

Nominated for Best Poster

Nominated for Best Integrated Human Practices

Nominated for Best Best Education & Public Engagement

Nominated for Best Measurement

Nominated for Best Composite Part

Nominated for Best Part Collection
Gallery

See the rest of our gallery...